Since the global recession in 2008 and the Eurozone crisis in 2009, nations across the globe have been subject to austerity measures impacting upon everything, including the pharma industry.
But what is the extent of this impact? We pose this question to several of our speakers from Evidence EU 2013 including:
- Sophie Murdoch, Alliance Life Sciences
- Brian Lovatt, Vision Healthcare Consultancy Ltd
- Dr Gordon Crawford, Patients Direct
Want to look in a little more detail at their answers?
Interested in finding out more about payer engagement, observational research, patient reported outcomes, design and use of patient registries and local evidence generation? Take a look at our Evidence EU 2014 event.